Organisation: Dura Pharmaceuticals

Sign in

Organisation: Dura Pharmaceuticals

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Elan shares rise after US Supreme Court ruling

Carey Sargent, Bloomberg

Thu, 21 Apr, 2005

Backing for MS drug boosts Elan

SHARES in Elan soared by 5.91% yesterday, adding €444 million to the value of the company.

Tue, 29 Jun, 2004